Author:
Rojas L,Neumann I,Herrero M José,Bosó V,Reig J,Poveda J Luis,Megías J,Bea S,Aliño S F
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference58 articles.
1. Webster A, Woodroffe RC, Taylor RS, Chapman JR, Craig JC . Tacrolimus versus cyclosporine as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev 2005; 19: CD003961.
2. Bowman LJ, Brennan DC . The role of tacrolimus in renal transplantation. Expert Opin Pharmacother 2008; 9: 635–643.
3. Barraclough KA, Isbel NM, Johnson DW, Campbell SB, Staatz CE . Once- versus twice-daily tacrolimus: are the formulations truly equivalent? Drugs 2011; 71: 1561–1577.
4. Dai Y, Hebert MF, Isoherranen N, Davis CL, Marsh C, Shen DD et al. Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro. Drug Metab Dispos 2006; 34: 836–847.
5. Choi JH, Lee YJ, Jang SB, Lee JE, Kim KH, Park K . Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects. Br J Clin Pharmacol 2007; 64: 185–191.
Cited by
122 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献